Literature DB >> 20079360

Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects.

Giuseppe Derosa1, Angela D'Angelo, Sibilla A T Salvadeo, Ilaria Ferrari, Elena Fogari, Alessia Gravina, Roberto Mereu, Ilaria Palumbo, Pamela Maffioli, Sabrina Randazzo, Arrigo F G Cicero.   

Abstract

We evaluated the effect of an oral glucose tolerance test (OGTT) on the level of biomarkers of vascular remodelling. We enrolled 256 Caucasian overweight healthy subjects (H) and 274 overweight type 2 diabetic patients (D). All patients underwent basal measurements of blood glucose (BG), nitrites/nitrates, adiponectin (ADP), matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) before and after OGTT. Nitrites/nitrates decrease was present after 60, 90, 120, and 180 min in both groups. Nitrite/nitrate levels were decreased at baseline, after 30 and 60 min in D group compared to H group. ADP decrease was present after 90, 120, and 180 min, in both groups. ADP levels were lower in D group than in H group during OGTT. MMP-2 increase was present after 60, 90, and 120 min in H group, while MMP-2 increase was observed after 90, 120, and 180 min in D group. MMP-2 levels were higher in D group than in H group during OGTT. MMP-9 increase was present in H group after 60, 90, 120, and 180 min, while MMP-9 increase was observed after 90, 120, and 180 min in D group. MMP-9 levels were higher in D group than in H group during OGTT. Postprandial glycemia induces an acute increase in biomarkers of vascular remodelling. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079360     DOI: 10.1016/j.mvr.2010.01.002

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  9 in total

1.  Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients.

Authors:  Ignatios Ikonomidis; George Pavlidis; Maria Tsoumani; Foteini Kousathana; Konstantinos Katogiannis; Damianos Tsilivarakis; John Thymis; Aikaterini Kountouri; Emmanouil Korakas; Loukia Pliouta; Athanasios Raptis; John Parissis; Ioanna Andreadou; Vaia Lambadiari
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

2.  Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity.

Authors:  Vanessa A Belo; Marcelo R Luizon; Patrícia C Carneiro; Valéria A Gomes; Riccardo Lacchini; Carla M M Lanna; Debora C Souza-Costa; Jose E Tanus-Santos
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

3.  The role of TNF-α G-308A promoter polymorphism in glycemic control in Type 2 diabetes patients.

Authors:  S I Al-Azzam; O F Khabour; K H Alzoubi; M W Ghanma; A Y Alhasan
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

4.  Acute interaction between oral glucose (75 g as Lucozade) and inorganic nitrate: Decreased insulin clearance, but lack of blood pressure-lowering.

Authors:  Christopher N Floyd; Satnam Lidder; Joanne Hunt; Sami A Omar; Karen McNeill; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2019-05-09       Impact factor: 4.335

Review 5.  A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus.

Authors:  Giuseppe Derosa; Pamela Maffioli
Journal:  Vasc Health Risk Manag       Date:  2016-11-09

6.  Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients.

Authors:  Giuseppe Derosa; Maria Divina Pascuzzo; Angela D'Angelo; Pamela Maffioli
Journal:  Diabetes Metab Syndr Obes       Date:  2019-09-18       Impact factor: 3.168

7.  α-Glucosidase inhibitors and their use in clinical practice.

Authors:  Giuseppe Derosa; Pamela Maffioli
Journal:  Arch Med Sci       Date:  2012-11-07       Impact factor: 3.318

8.  Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges.

Authors:  Suzan Wopereis; Danielle Wolvers; Marjan van Erk; Michiel Gribnau; Bas Kremer; Ferdi A van Dorsten; Esther Boelsma; Ursula Garczarek; Nicole Cnubben; Leon Frenken; Paul van der Logt; Henk F J Hendriks; Ruud Albers; John van Duynhoven; Ben van Ommen; Doris M Jacobs
Journal:  BMC Med Genomics       Date:  2013-10-27       Impact factor: 3.063

Review 9.  Hypoglycemic agents and potential anti-inflammatory activity.

Authors:  Vishal Kothari; John A Galdo; Suresh T Mathews
Journal:  J Inflamm Res       Date:  2016-04-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.